Education
About Us
Working with TipRanks
Follow Us
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
Total Valuation
Bal Pharma Limited has a market cap or net worth of ₹1.29B. The enterprise value is ₹3.46B.
Market Cap₹1.29B
Enterprise Value₹3.46B
Share Statistics
Bal Pharma Limited has 15,920,872 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,920,872
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bal Pharma Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 11.85%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)11.85%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee3.49M
Profits Per Employee83.13K
Employee Count868
Asset Turnover0.90
Inventory Turnover2.23
Valuation Ratios
The current PE Ratio of Bal Pharma Limited is 15.1. Bal Pharma Limited’s PEG ratio is -2.36.
PE Ratio15.1
PS Ratio0.43
PB Ratio1.69
Price to Fair Value1.69
Price to FCF-9.00
Price to Operating Cash Flow0.00
PEG Ratio-2.36
Income Statement
In the last 12 months, Bal Pharma Limited had revenue of 3.03B and earned 72.15M in profits. Earnings per share was 4.56.
Revenue3.03B
Gross Profit730.18M
Operating Income197.89M
Pretax Income51.38M
Net Income72.15M
EBITDA317.63M
Earnings Per Share (EPS)4.56
Cash Flow
In the last 12 months, operating cash flow was 88.16M and capital expenditures -76.88M, giving a free cash flow of 11.28M billion.
Operating Cash Flow88.16M
Free Cash Flow11.28M
Free Cash Flow per Share0.71
Dividends & Yields
Bal Pharma Limited pays an annual dividend of ₹1.2, resulting in a dividend yield of 1.49%
Dividend Per Share₹1.2
Dividend Yield1.49%
Payout Ratio22.59%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change-32.59%
50-Day Moving Average86.27
200-Day Moving Average96.67
Relative Strength Index (RSI)35.27
Average Volume (3m)4.08K
Important Dates
Bal Pharma Limited upcoming earnings date is Nov 14, 2025, TBA (Confirmed).
Last Earnings DateAug 11, 2025
Next Earnings DateNov 14, 2025
Ex-Dividend DateSep 18, 2025
Financial Position
Bal Pharma Limited as a current ratio of 1.07, with Debt / Equity ratio of 194.29%
Current Ratio1.07
Quick Ratio0.60
Debt to Market Cap1.15
Net Debt to EBITDA4.48
Interest Coverage Ratio1.17
Taxes
In the past 12 months, Bal Pharma Limited has paid -20.99M in taxes.
Income Tax-20.99M
Effective Tax Rate-0.41
Enterprise Valuation
Bal Pharma Limited EV to EBITDA ratio is 8.61, with an EV/FCF ratio of -18.78.
EV to Sales0.90
EV to EBITDA8.61
EV to Free Cash Flow-18.78
EV to Operating Cash Flow64.59
Balance Sheet
Bal Pharma Limited has ₹105.19M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹105.19M billion.
Cash & Marketable Securities₹105.19M
Total Debt₹0.00
Net Cash₹105.19M
Net Cash Per Share₹6.61
Tangible Book Value Per Share₹42.23
Margins
Gross margin is 42.28%, with operating margin of 6.53%, and net profit margin of 2.38%.
Gross Margin42.28%
Operating Margin6.53%
Pretax Margin1.70%
Net Profit Margin2.38%
EBITDA Margin10.48%
EBIT Margin7.26%
Analyst Forecast
The average price target for Bal Pharma Limited is ₹92.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹92.00
Price Target Upside13.76% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-14.16%
EPS Growth Forecast10.85%